NZ247083A - Benzofuran-, and benzothiophene- and indole- sulphonamide derivatives and antineoplastic compositions thereof - Google Patents

Benzofuran-, and benzothiophene- and indole- sulphonamide derivatives and antineoplastic compositions thereof

Info

Publication number
NZ247083A
NZ247083A NZ247083A NZ24708393A NZ247083A NZ 247083 A NZ247083 A NZ 247083A NZ 247083 A NZ247083 A NZ 247083A NZ 24708393 A NZ24708393 A NZ 24708393A NZ 247083 A NZ247083 A NZ 247083A
Authority
NZ
New Zealand
Prior art keywords
sulfonamide
carbonyl
amino
halo
alkyl
Prior art date
Application number
NZ247083A
Other languages
English (en)
Inventor
Fariborz Mohamadi
Michael Marriott Spees
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NZ247083A publication Critical patent/NZ247083A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Indole Compounds (AREA)
NZ247083A 1992-03-13 1993-03-08 Benzofuran-, and benzothiophene- and indole- sulphonamide derivatives and antineoplastic compositions thereof NZ247083A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/850,531 US5169860A (en) 1992-03-13 1992-03-13 Antitumor compositions and methods of treatment

Publications (1)

Publication Number Publication Date
NZ247083A true NZ247083A (en) 1995-09-26

Family

ID=25308394

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ247083A NZ247083A (en) 1992-03-13 1993-03-08 Benzofuran-, and benzothiophene- and indole- sulphonamide derivatives and antineoplastic compositions thereof

Country Status (19)

Country Link
US (1) US5169860A (Direct)
EP (1) EP0560554A2 (Direct)
JP (1) JPH0649052A (Direct)
KR (1) KR930019655A (Direct)
CN (1) CN1076447A (Direct)
AU (2) AU662605B2 (Direct)
BR (1) BR9301137A (Direct)
CA (1) CA2091207A1 (Direct)
CZ (1) CZ36893A3 (Direct)
FI (1) FI931085L (Direct)
HU (1) HUT63830A (Direct)
IL (1) IL104981A0 (Direct)
MX (1) MX9301296A (Direct)
MY (1) MY111178A (Direct)
NO (1) NO930891L (Direct)
NZ (1) NZ247083A (Direct)
TW (1) TW215083B (Direct)
YU (1) YU16893A (Direct)
ZA (1) ZA931645B (Direct)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254582A (en) * 1992-02-05 1993-10-19 Eli Lilly And Company Antitumor compositions and methods
US5270329A (en) * 1992-12-10 1993-12-14 Eli Lilly And Company Antitumor compositions and methods of treatment
CA2110524A1 (en) * 1992-12-10 1994-06-11 Gerald Burr Grindey Antitumor compositions and methods of treatment
ZA941500B (en) * 1993-03-10 1995-09-04 Lilly Co Eli Antitumor compositions and methods of treatment
US5529999A (en) * 1994-03-04 1996-06-25 Eli Lilly And Company Antitumor compositions and methods of treatment
CO4410191A1 (es) 1994-09-19 1997-01-09 Lilly Co Eli SINTESIS DE 3-[4-(2-AMINOETOXI)BENZOIL]-2-ARIL-6- HIDROXIBENZO [b] TIOFENOS
US5629425A (en) * 1994-09-19 1997-05-13 Eli Lilly And Company Haloalkyl hemisolvates of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-piperidinoethoxy)-benzoyl]benzo[b]thiophene
US5863936A (en) * 1995-04-18 1999-01-26 Geron Corporation Telomerase inhibitors
US6008377A (en) * 1996-03-19 1999-12-28 Eli Lilly And Company Synthesis of 3-[4-(2-aminoethoxy)-benzoyl]-2-aryl-6-hydroxy-benzo[B]thiophenes
DE69708340T2 (de) * 1996-08-22 2002-05-16 Dong Wha Pharmaceutical Industrial Co. Ltd., Seoul Arylsulfonylimidazolon-derivate als antitumormittel
EP0929540A4 (en) * 1996-10-04 2001-12-12 Lilly Co Eli ANTI-TUMOR COMPOSITIONS AND THERAPEUTIC METHODS
JP2000247949A (ja) * 1999-02-26 2000-09-12 Eisai Co Ltd スルホンアミド含有インドール化合物
ES2156550B1 (es) * 1999-04-19 2002-02-01 Univ Navarra Publica Derivados de benzo(b) tiofenosulfonamida-1,1-dioxido y su uso como agentes antineoplasicos.
JP4505876B2 (ja) * 1999-05-25 2010-07-21 東ソー株式会社 ４−ハロベンゾフラン誘導体及びその製造方法
TWI281916B (en) * 2001-10-25 2007-06-01 Lilly Co Eli Antitumor compounds and methods
US20050119318A1 (en) * 2003-10-31 2005-06-02 Hudyma Thomas W. Inhibitors of HCV replication
AU2008329677B2 (en) 2007-11-28 2015-02-19 Sequoia Pharmaceuticals, Inc. Compositions and methods for inhibiting cytochrome P450 2D6
KR101300702B1 (ko) * 2011-01-20 2013-08-26 대우조선해양 주식회사 탈가스 장치
CN103450149B (zh) * 2012-06-01 2015-10-14 中国科学院上海有机化学研究所 苯基噻吩磺酰胺类化合物及其制备方法和用途
CN104564805B (zh) * 2013-10-29 2017-11-10 海尔集团公司 一种离心风机的扇叶结构、离心风机及嵌入式空调内机
SMT202000192T1 (it) 2015-02-16 2020-05-08 Univ Queensland Solfoniluree e composti correlati e utilizzo degli stessi
MA44729A (fr) 2016-04-18 2021-05-12 Novartis Ag Composés et compositions pour traiter des états associés à une activité de nlrp
EP3661925B1 (en) 2017-07-07 2021-11-24 Inflazome Limited Novel sulfonamide carboxamide compounds
CA3068836A1 (en) 2017-07-24 2019-01-31 Novartis Inflammasome Research, Inc. Compounds and compositions for treating conditions associated with nlrp activity
RU2020110219A (ru) 2017-08-15 2021-09-17 Инфлазоум Лимитед Сульфонилмочевины и сульфонилтиомочевины в качестве ингибиторов nlrp3
WO2019034692A1 (en) 2017-08-15 2019-02-21 Inflazome Limited SULFONYLURATES AND SULFONYLTHIOURES AS INHIBITORS OF NLRP3
EP3668843A1 (en) 2017-08-15 2020-06-24 Inflazome Limited Sulfonylureas and sulfonylthioureas as nlrp3 inhibitors
BR112020008981A2 (pt) 2017-11-09 2020-11-17 Inflazome Limited novos compostos de sulfonamida carboxamida
US12221434B2 (en) 2017-11-09 2025-02-11 Inflazome Limited Sulfonamide carboxamide compounds
US11905252B2 (en) 2018-03-02 2024-02-20 Inflazome Limited Compounds
JP2022505525A (ja) * 2018-10-24 2022-01-14 ノバルティス アーゲー Ｎｌｒｐ活性に関連する状態を治療するための化合物及び組成物
CN109384764B (zh) * 2018-12-12 2021-09-03 中国科学院上海有机化学研究所 苯基噻吩磺酰胺类化合物、药物组合物、其制备方法和应用
WO2022022646A1 (zh) * 2020-07-29 2022-02-03 南京明德新药研发有限公司 含硒五元杂芳环化合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3083207A (en) * 1963-03-26 Indolinesulfonylureas
DE1144259B (de) * 1956-05-29 1963-02-28 Hoechst Ag Verfahren zur Herstellung von Sulfonylharnstoffen
US3097242A (en) * 1960-06-29 1963-07-09 Olin Mathieson Hydrindene sulfonylureas
DE1240866B (de) * 1961-06-29 1967-05-24 Heyden Chem Fab Verfahren zur Herstellung von Indolin-6-sulfonylharnstoffen
US3102121A (en) * 1961-06-29 1963-08-27 Olin Mathieson Novel cumaransulfonylureas and 2,3-dihydrothionaphthenesulfonylureas
GB1050447A (Direct) * 1962-04-11
US3849110A (en) * 1963-01-07 1974-11-19 Lilly Co Eli Herbicidal method employing aryl-sulfonylureas or salts thereof
US3736122A (en) * 1969-04-10 1973-05-29 C Tung Method of controlling plant growth
IL69621A0 (en) * 1982-09-02 1983-12-30 Duphar Int Res Pharmaceutical compositions having antitumor activity,comprising certain phenylurea derivatives
CA1208561A (en) * 1984-01-19 1986-07-29 Marius S. Brouwer Pharmaceutical compositions containing benzoylurea compounds
US4845128A (en) * 1984-06-27 1989-07-04 Eli Lilly And Company N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides
IL80032A (en) * 1985-09-23 1992-07-15 Lilly Co Eli Anti-tumor phenyl-aminocarbonylsulfonamides,their preparation and pharmaceutical compositions containing them
CA1331464C (en) * 1987-05-12 1994-08-16 Eli Lilly And Company Anti-tumor method and compounds
NZ238911A (en) * 1990-07-17 1993-10-26 Lilly Co Eli Furyl, pyrrolyl and thienyl sulphonyl urea derivatives, pharmaceutical compositions and intermediates therefor

Also Published As

Publication number Publication date
CZ36893A3 (en) 1994-04-13
JPH0649052A (ja) 1994-02-22
AU3519893A (en) 1993-09-16
MX9301296A (es) 1993-10-01
NO930891L (no) 1993-09-14
YU16893A (sh) 1996-07-24
CN1076447A (zh) 1993-09-22
ZA931645B (en) 1994-09-08
FI931085A0 (fi) 1993-03-11
CA2091207A1 (en) 1993-09-14
HUT63830A (en) 1993-10-28
NO930891D0 (no) 1993-03-11
IL104981A0 (en) 1993-07-08
EP0560554A2 (en) 1993-09-15
AU662605B2 (en) 1995-09-07
BR9301137A (pt) 1993-09-28
EP0560554A3 (Direct) 1994-01-19
HU9300688D0 (en) 1993-05-28
FI931085A7 (fi) 1993-09-14
KR930019655A (ko) 1993-10-18
US5169860A (en) 1992-12-08
TW215083B (Direct) 1993-10-21
FI931085L (fi) 1993-09-14
AU4028995A (en) 1996-02-15
MY111178A (en) 1999-09-30

Similar Documents

Publication Publication Date Title
AU662605B2 (en) Antitumor compositions and methods of treatment
AU640499B2 (en) Antitumor compositions and methods of treatment
IE59588B1 (en) Sulfonyl ureas with anti-tumour activity
JPH0714881B2 (ja) ベンゼンスルホンアミド類およびその改良
US5254582A (en) Antitumor compositions and methods
US5270329A (en) Antitumor compositions and methods of treatment
US5594028A (en) Anti-tumor method and compounds
EP0602878A1 (en) Diarylsulfonylureas and their use as antitumor agents
EP0614887B1 (en) Indole-sulfonamides as antitumor agents
US5262440A (en) Antitumor compositions and methods of treatment
EP0672662A1 (en) Quinoxaline derivative used in the treatment of tumours
US5827879A (en) Antitumor compositions and methods of treatment
US6174921B1 (en) Antitumor compositions and methods of treatment
WO1998014185A1 (en) Antitumor compositions and methods of treatment